Association of IL-4-590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population

International Journal of Immunogenetics

Volumn 37, Issue 6, 2010, Pages 459-465

  Zhu, J ^a   Ju, X ^a   Yan, F ^b   Qin, C ^a   Wang, M ^b   Ding, Q ^a   Zhang, Z ^b   Yin, C ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-4; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 77958527474     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00948.x     Document Type: Article

References (36)

1. Banchereau, J., Briere, F., Galizzi, J.P., Miossec, P. & Rousset, F. (1994) Human Interleukin 4. Journal of Lipid Mediators and Cell Signalling, 9, 43.
2. Chatterjee, A., Rathore, A. & Dhole, T.N. (2009) Association of IL-4 589 C/T promoter and IL-4 ralphai50v receptor polymorphism with susceptibility to HIV-1 infection in north Indians. Journal of Medical Virology, 81, 959.
3. Cheon, J., Chung, D.J., Kim, J.J., Koh, S.K. & Sohn, J. (1996) Inhibitory effects of Interleukin-4 on human renal cell carcinoma cells in vitro: in combination with Interferon-alpha, tumor necrosis factor-alpha or Interleukin-2. International Journal of Urology, 3, 196.
4. Cohen, H.T. & McGovern, F.J. (2005) Renal-cell carcinoma. New England Journal of Medicine, 353, 2477.
5. Falkensammer, C., Johrer, K., Gander, H., Ramoner, R., Putz, T., Rahm, A., Greil, R., Bartsch, G. & Thurnher, M. (2006) IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (rcc) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by rcc: implications for antitumor immune responses. Cancer Immunology, Immunotherapy, 55, 1228.
6. Finke, J.H., Rini, B., Ireland, J., Rayman, P., Richmond, A., Golshayan, A. et al. (2008) Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clinical Cancer Research, 14, 6674.
7. Howell, W.M., Turner, S.J., Theaker, J.M. & Bateman, A.C. (2003) Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. European Journal of Immunogenetics, 30, 409.
8. Hunt, J.D., Van Der Hel, O.L., McMillan, G.P., Boffetta, P. & Brennan, P. (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. International Journal of Cancer, 114, 101.
9. Ikemoto, S., Yoshida, N., Narita, K., Wada, S., Kishimoto, T., Sugimura, K. & Nakatani, T. (2003) Role of tumor-associated macrophages in renal cell carcinoma. Oncology Reports, 10, 1843.
10. Janzen, N.K., Kim, H.L., Figlin, R.A. & Belldegrun, A.S. (2003) Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urologic Clinics of North America, 30, 843.
11. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. & Thun, M.J. (2009) Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225.
12. Kelso, A. (1998) Cytokines: principles and prospects. Immunology and Cell Biology, 76, 300.
13. Kim, Y.K., Pyo, C.W., Choi, H.B., Kim, S.Y., Kim, T.Y. & Kim, T.G. (2007) Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the korean population. Journal of Dermatological Science, 48, 133.
14. Kleinrath, T., Gassner, C., Lackner, P., Thurnher, M. & Ramoner, R. (2007) Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. Journal of Clinical Oncology, 25, 845.
15. Kubo, M., Yamashita, M., Abe, R., Tada, T., Okumura, K., Ransom, J.T. & Nakayama, T. (1999) CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation. Journal of Immunology, 163, 2432.
16. Landi, S., Bottari, F., Gemignani, F., Gioia-Patricola, L., Guino, E., Osorio, A., De Oca, J., Capella, G., Canzian, F. & Moreno, V. (2007) Interleukin-4 and Interleukin-4 receptor polymorphisms and colorectal cancer risk. European Journal of Cancer, 43, 762.
17. Lipworth, L., Tarone, R.E. & McLaughlin, J.K. (2006) The epidemiology of renal cell carcinoma. Journal of Urology, 176, 2353.
18. Margolin, K., Aronson, F.R., Sznol, M., Atkins, M.B., Gucalp, R., Fisher, R.I. et al. (1994) Phase II studies of recombinant human Interleukin-4 in advanced renal cancer and malignant melanoma. Journal of Immunotherapy with Emphasis on Tumor Immunology, 15, 147.
19. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology, 136, 2348.
20. Motzer, R.J., Mazumdar, M., Bacik, J., Russo, P., Berg, W.J. & Metz, E.M. (2000) Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. Journal of Clinical Oncology, 18, 1928.
21. Obiri, N.I., Hillman, G.G., Haas, G.P., Sud, S. & Puri, R.K. (1993) Expression of high affinity Interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by Interleukin-4. Journal of Clinical Investigation, 91, 88.
22. Obiri, N.I., Husain, S.R., Debinski, W. & Puri, R.K. (1996) Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 Interleukin 4 receptor chain. Clinical Cancer Research, 2, 1743.
23. Pardoll, D.M. & Topalian, S.L. (1998) The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology, 10, 588.
24. Paul, W.E. & Seder, R.A. (1994) Lymphocyte responses and cytokines. Cell, 76, 241.
25. Rosenwasser, L.J., Klemm, D.J., Dresback, J.K., Inamura, H., Mascali, J.J., Klinnert, M. & Borish, L. (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clinical and Experimental Allergy, 25(Suppl 2), 74. discussion 95-6.
26. Schwarz, M.J., Kronig, H., Riedel, M., Dehning, S., Douhet, A., Spellmann, I., Ackenheil, M., Moller, H.J. & Muller, N. (2006) IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 256, 72.
27. Setiawan, V.W., Stram, D.O., Nomura, A.M., Kolonel, L.N. & Henderson, B.E. (2007) Risk factors for renal cell cancer: the multiethnic cohort. American Journal of Epidemiology, 166, 932.
28. Smith, A.J. & Humphries, S.E. (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine and Growth Factor Reviews, 20, 43.
29. Thurnher, M., Radmayr, C., Hobisch, A., Bock, G., Romani, N., Bartsch, G. & Klocker, H. (1995) Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation. International Journal of Cancer, 62, 559.
30. Thurnher, M., Radmayr, C., Ramoner, R., Ebner, S., Bock, G., Klocker, H., Romani, N. & Bartsch, G. (1996) Human renal-cell carcinoma tissue contains dendritic cells. International Journal of Cancer, 68, 1.
31. Toes, R.E., Ossendorp, F., Offringa, R. & Melief, C.J. (1999) CD4 T cells and their role in antitumor immune responses. Journal of Experimental Medicine, 189, 753.
32. Watanabe, Y., Nunokawa, A., Shibuya, M., Kaneko, N., Nawa, H. & Someya, T. (2008) Association study of Interleukin 2 (IL2) and IL4 with schizophrenia in a japanese population. European Archives of Psychiatry and Clinical Neuroscience, 258, 422.
33. Whitehead, R.P., Unger, J.M., Goodwin, J.W., Walker, M.J., Thompson, J.A., Flaherty, L.E. & Sondak, V.K. (1998) Phase II trial of recombinant human Interleukin-4 in patients with disseminated malignant melanoma: a southwest oncology group study. Journal of Immunotherapy, 21, 440.
34. Whitehead, R.P., Lew, D., Flanigan, R.C., Weiss, G.R., Roy, V., Glode, M.L., Dakhil, S.R. & Crawford, E.D. (2002) Phase II trial of recombinant human Interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study. Journal of Immunotherapy, 25, 352.
35. Wu, J., Lu, Y., Ding, Y.B., Ke, Q., Hu, Z.B., Yan, Z.G. et al. (2009) Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk chinese population. Molecular Carcinogenesis, 48, 626.
36. Yu, S.J., Kim, H.S., Cho, S.W. & Sohn, J. (2004) IL-4 inhibits proliferation of renal carcinoma cells by increasing the expression of p21WAF1 and IRF-1. Experimental & Molecular Medicine, 36, 372.